18484337|t|Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients.
18484337|a|There is accumulating evidence of the involvement of biological metal imbalance in the progression of amyloid diseases such as Alzheimer's, Parkinson's and prion diseases. However, the mineral status in patients affected with familial amyloidotic polyneuropathy (FAP) has not been investigated. It is the aim of this study to determine the metal concentrations in the serum and in the transthyretin (TTR) amyloid fibrils of FAP amyloidogenic TTR (ATTR) V30M patients. Multi-elemental analysis of 17 metals by high-resolution inductively coupled plasma mass spectrometry (ICP-MS) revealed a significant decrease of the metals Fe, Cu, Zn, Cs and Ba in the serum of FAP patients (mean age 38.5 +/- 8.3 years; duration of disease 4 +/- 2.6 years) in comparison with that of healthy individuals (mean age 36.2 +/- 9.2 years). On the other hand, these metals, except Cs, were found at high levels in the amyloid fibrils of FAP patients (mean age 55.8 +/- 9.2; duration of disease 6.5 +/- 1.3 years) compared with other metals. These findings firstly suggest that the mineral status could be a candidate factor, which participates in the wide spectrum of clinical pictures of FAP patients.
18484337	57	88	familial amyloid polyneuropathy	Disease	MESH:D028227
18484337	89	97	patients	Species	9606
18484337	163	168	metal	Chemical	MESH:D008670
18484337	201	217	amyloid diseases	Disease	MESH:C000718787
18484337	226	237	Alzheimer's	Disease	MESH:D000544
18484337	239	250	Parkinson's	Disease	MESH:D010300
18484337	255	269	prion diseases	Disease	MESH:D017096
18484337	302	310	patients	Species	9606
18484337	325	360	familial amyloidotic polyneuropathy	Disease	MESH:D028227
18484337	362	365	FAP	Disease	MESH:D028227
18484337	439	444	metal	Chemical	MESH:D008670
18484337	484	497	transthyretin	Gene	7276
18484337	499	502	TTR	Gene	7276
18484337	523	544	FAP amyloidogenic TTR	Disease	MESH:D028227
18484337	546	550	ATTR	Disease	MESH:C567782
18484337	552	556	V30M	ProteinMutation	tmVar:p|SUB|V|30|M;HGVS:p.V30M;VariantGroup:0;CorrespondingGene:7276;RS#:28933979;CorrespondingSpecies:9606;CA#:256790
18484337	557	565	patients	Species	9606
18484337	724	726	Fe	Chemical	MESH:D007501
18484337	728	730	Cu	Chemical	MESH:D003300
18484337	732	734	Zn	Chemical	MESH:D015032
18484337	736	738	Cs	Chemical	MESH:D002586
18484337	743	745	Ba	Chemical	MESH:D001464
18484337	762	765	FAP	Disease	MESH:D028227
18484337	766	774	patients	Species	9606
18484337	960	962	Cs	Chemical	MESH:D002586
18484337	1016	1019	FAP	Disease	MESH:D028227
18484337	1020	1028	patients	Species	9606
18484337	1268	1271	FAP	Disease	MESH:D028227
18484337	1272	1280	patients	Species	9606
18484337	Association	MESH:D028227	RS#:28933979;HGVS:p.V30M;CorrespondingGene:7276
18484337	Negative_Correlation	MESH:D015032	MESH:D028227
18484337	Negative_Correlation	MESH:D003300	MESH:D028227
18484337	Negative_Correlation	MESH:D007501	MESH:D028227
18484337	Association	MESH:D028227	7276
18484337	Association	MESH:D008670	MESH:D000544
18484337	Negative_Correlation	MESH:D001464	MESH:D028227
18484337	Association	MESH:D002586	MESH:D028227
18484337	Association	MESH:D008670	MESH:D010300
18484337	Association	MESH:D008670	MESH:C000718787
18484337	Association	MESH:D008670	MESH:D017096
18484337	Association	MESH:D028227	7276

